Anti-Human ALCAM (3A6)

ALCAM Monoclonal Antibody for FC

Host / Isotype

Mouse / IgG1, kappa

Reactivity

Human

Applications

FC

Conjugate

Unconjugated

CloneNo.

3A6

Cat no : 65223-1-Ig

Synonyms

ALCAM, CD166, CD166 antigen, FLJ38514, MEMD

---

Validation Data Gallery

• 

  FC experiment of human PBMCs using 65223-1-Ig

  1X10^6 PHA treated human PBMCs were surface stained with 0.2 ug Anti-Human ALCAM (65223-1-Ig, Clone:3A6) and CL594-Goat anti-Mouse IgG at dilution 1:1000 (red) or unstained (blue). Cells were not fixed. Monocytes were gated.

---

Tested Applications

• Positive FC detected in: PHA treated human PBMCs

Recommended dilution

Application	Dilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

65223-1-Ig targets ALCAM in FC applications and shows reactivity with Human samples.

• Tested Reactivity: Human
• Host / Isotype: Mouse / IgG1, kappa
• Class: Monoclonal
• Type: Antibody
• Immunogen: Cultured human thymic epithelial cells
• Full Name: activated leukocyte cell adhesion molecule
• Calculated Molecular Weight: 105 kDa
• GenBank Accession Number: BC057809
• Gene Symbol: ALCAM
• Gene ID (NCBI): 214
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Affinity purification
• Storage Buffer: PBS with 0.09% sodium azide.
• Storage Conditions: Store at 2-8°C. Stable for one year after shipment.

Background Information

Activated leukocyte cell adhesion molecule (ALCAM, also known as CD166) is a cell adhesion molecule that belongs to the immunoglobulin superfamily. It is involved in cell-cell adhesion through homophilic and heterophilic (to CD6) interactions. ALCAM is widely expressed in a variety of normal tissues and cell types, including activated T cells and monocytes, epithelial cells, fibroblasts, neuronal cells, hepatocytes, and bone marrow mesenchymal stem cells (PMID: 7760007; 25221999). Altered ALCAM expression has been associated with the differentiation state and progression in some neoplasms including melanoma, prostate, colorectal, and breast cancers (PMID: 20461761; 18172759).